Showing 1 - 3 results of 3 for search 'Luca Vivona', query time: 1.25s
Refine Results
-
1
The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management by Michela Roberto, Martina Panebianco, Anna Maria Aschelter, Dorelsa Buccilli, Carmen Cantisani, Salvatore Caponnetto, Enrico Cortesi, Sara d’Amuri, Claudia Fofi, Debora Ierinò, Viviana Maestrini, Paolo Marchetti, Massimo Marignani, Antonio Stigliano, Luca Vivona, Daniele Santini, Silverio Tomao
Published 2023-01-01
Article -
2
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis by Alessio Cirillo, Daniele Marinelli, Umberto Romeo, Daniela Messineo, Francesca De Felice, Marco De Vincentiis, Valentino Valentini, Silvia Mezi, Filippo Valentini, Luca Vivona, Antonella Chiavassa, Bruna Cerbelli, Daniele Santini, Paolo Bossi, Antonella Polimeni, Paolo Marchetti, Andrea Botticelli
Published 2024-04-01
Article -
3
Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis by Alessio Cirillo, Daniele Marinelli, Umberto Romeo, Daniela Messineo, Francesca De Felice, Marco De Vincentiis, Valentino Valentini, Silvia Mezi, Filippo Valentini, Luca Vivona, Antonella Chiavassa, Bruna Cerbelli, Daniele Santini, Paolo Bossi, Antonella Polimeni, Paolo Marchetti, Andrea Botticelli
Published 2024-04-01
Article